SEC Form 4 · accession 0001209191-18-025646
AKCEA THERAPEUTICS, INC. · AKCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
IONIS PHARMACEUTICALS INC
10% Owner
Period of report
Apr 17, 2018
Accepted (ET)
Apr 19, 2018 · 6:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001662524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 17, 2018 | J | 8,000,000 | — | A | 53,447,879 | D | |
| Common Stock | Apr 17, 2018 | P | 10,666,666 | $18.75 | A | 64,114,545 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued in satisfaction of the Issuer's obligations to the Reporting Person pursuant to that certain License Agreement, dated March 14, 2018, between the Issuer and the Reporting Person.
- F2Shares purchased pursuant to that certain Stock Purchase Agreement, dated March 14, 2018, between the Issuer and the Reporting Person.